Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease

References

• Aberle J, Flitsch J, Beck NA, Mann O, Busch P, Peitsmeier P, Beil FU. 2008. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol Genet Metab 95:188–191
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. 2005. The metabolic syndrome – a new worldwide definition. Lancet 366:1059–1062
   PubMed Web of Science ®Google Scholar
• Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis C. 2008. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract 62:1432–1440
   PubMed Web of Science ®Google Scholar
• Bruce KD, Hanson MA. 2010. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 140:648–652
   PubMed Web of Science ®Google Scholar
• Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O’Donovan MC. 2005. Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26:214–223
   PubMed Web of Science ®Google Scholar
• Buckland PR, Hoogendoorn B, Guy CA, Coleman SL, Smith SK, Buxbaum JD, Haroutunian V, O’Donovan MC. 2004. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta 1690:238–249
   PubMed Web of Science ®Google Scholar
• Campbell CD, Lyon HN, Nemesh J, Drake JA, Tuomi T, Gaudet D, Zhu X, et al. 2007. Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes 56:1460–1467
   PubMed Web of Science ®Google Scholar
• Ding B, Kull B, Liu Z, Mottagui-Tabar S, Thonberg H, Gu HF, Brookes AJ, et al. 2005. Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept 127:45–53
   PubMed Web of Science ®Google Scholar
• Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, et al. 2008. Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147B:510–516
   PubMed Web of Science ®Google Scholar
• Drevets WC, Savitz J, Trimble M. 2008. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13:663–681
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome. Lancet 365:1415–1428
   PubMed Web of Science ®Google Scholar
• Erkkila AT, Lindi V, Lehto S, Laakso M, Uusitupa MI. 2002. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab 75:260–264
   PubMed Web of Science ®Google Scholar
• Ghayour-Mobarhan M, Sahebkar A, Parizadeh SM, Moohebati M, Tavallaie S, Rezakazemi-Bajestani SM, Esmaeili HA, Ferns G. 2008. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol 89:209–215
   PubMed Web of Science ®Google Scholar
• Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjogren M, Asberg M, et al. 2004. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38:113–121
   PubMed Web of Science ®Google Scholar
• Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, Ujike H, et al. 2003. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett 347:202–204
   PubMed Web of Science ®Google Scholar
• Kelishadi R, Gharipour M, Sadri GH, Tavasoli AA, Amani A. 2008. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population. East Mediterr Health J 14:1070–1079
   PubMedGoogle Scholar
• Kim NS, Oh SM, Ko MM, Cha MH, Kang BK, Bang OS. 2009. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke. Clin Biochem 42:1699–1704
   PubMed Web of Science ®Google Scholar
• Lameira D, Lejeune S, Mourad JJ. 2008. Metabolic syndrome: epidemiology and its risks. Ann Dermatol Venereol 135:S249–S253
   PubMed Web of Science ®Google Scholar
• Lindberg C, Koefoed P, Hansen ES, Bolwig TG, Rehfeld JF, Mellerup E, Jorgensen OS, et al. 2006. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr Scand 113:54–58
   PubMed Web of Science ®Google Scholar
• Menyhert J, Wittmann G, Hrabovszky E, Keller E, Liposits Z, Fekete C. 2006. Interconnection between orexigenic neuropeptide Y- and anorexigenic alpha-melanocyte stimulating hormone-synthesizing neuronal systems of the human hypothalamus. Brain Res 1076:101–105
   PubMed Web of Science ®Google Scholar
• Mitchell GC, Wang Q, Ramamoorthy P, Whim MD. 2008. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 28:14428–14434
   PubMed Web of Science ®Google Scholar
• Nezhad MA, Ghayour-Mobarhan M, Parizadeh SM, Safarian M, Esmaeili H, Khodaei GH, Kazemi-Bajestani SM, et al. 2008. Metabolic syndrome: its prevalence and relationship to socio-economic parameters in an Iranian population. Nutr Metab Cardiovasc Dis 18:e11–e12
   PubMedGoogle Scholar
• Pan WH, Yeh WT, Weng LC. 2008. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr 17:37–42
   PubMed Web of Science ®Google Scholar
• Patel HR, Qi Y, Hawkins EJ, Hileman SM, Elmquist JK, Imai Y, Ahima RS. 2006. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes 55:3091–3098
   PubMed Web of Science ®Google Scholar
• Pons J, Lee EW, Li L, Kitlinska J. 2004. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases. Curr Opin Investig Drugs 5:957–962
   PubMedGoogle Scholar
• Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. 2003. Metabolic syndrome in urban Asian Indian adults – a population study using modified ATP III criteria. Diabetes Res Clin Pract 60:199–204
   PubMed Web of Science ®Google Scholar
• Rohner-Jeanrenaud E, Jeanrenaud B. 1997. Central nervous system and body weight regulation. Ann Endocrinol (Paris) 58:137–142
   PubMed Web of Science ®Google Scholar
• Sarrafzadegan N, Kelishadi R, Baghaei A, Hussein Sadri G, Malekafzali H, Mohammadifard N, Rabiei K, et al. 2008. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program. Int J Cardiol 131:90–96
   PubMed Web of Science ®Google Scholar
• Sattar N, Mcconnachie A, Shaper AG, Blauw GJ, Buckley BM, De Craen AJ, Ford I, et al. 2008. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927–1935
   PubMed Web of Science ®Google Scholar
• Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, et al. 2009. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet 5:e1000318
   PubMedGoogle Scholar
• Shahbazian H, Latifi SM, Jalali MT, Amani R, Nikhoo A, Aleali AM. 2013. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diabetes Metab Disord 12:11. doi: 10.1186/2251-6581-12-11
   Google Scholar
• Shine J, Potter EK, Biden T, Selbie LA, Herzog H. 1994. Neuropeptide Y and regulation of the cardiovascular system. J Hypertens Suppl 12:S41–S45
   PubMedGoogle Scholar
• Sitticharoon C, Chatree S, Churintaraphan M. 2013. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Regul Pept 185:65–72
   PubMed Web of Science ®Google Scholar
• Sommer WH, Lidstrom J, Sun H, Passer D, Eskay R, Parker SC, Witt SH, et al. 2010. Human NPY promoter variation rs16147:T > C as a moderator of prefrontal NPY gene expression and negative affect. Hum Mutat 31:E1594–E1608
   PubMed Web of Science ®Google Scholar
• Turi GF, Liposits Z, Moenter SM, Fekete C, Hrabovszky E. 2003. Origin of neuropeptide Y-containing afferents to gonadotropin-releasing hormone neurons in male mice. Endocrinology 144:4967–74
   PubMed Web of Science ®Google Scholar
• Ukkola O, Kesaniemi YA. 2007. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. Eur J Clin Nutr 61:1102–1105
   PubMed Web of Science ®Google Scholar
• Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. 2012. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension 60:1169–1175
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, et al. 2008. Genetic variation in human NPY expression affects stress response and emotion. Nature 452:997–1001
   PubMed Web of Science ®Google Scholar